XML 28 R99.htm IDEA: XBRL DOCUMENT v3.19.3
Supplemental Guarantor Information - Condensed Consolidating Statements of Cash Flows (Details) - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2017
Condensed Financial Statements, Captions [Line Items]      
Net cash (used in) provided by operating activities $ 113,635 $ 54,838 $ 104,862
Cash flows from investing activities:      
Capital expenditures (21,356) (17,020) (12,440)
Proceeds from sale of fixed assets 251 370 297
Acquisition, net of cash acquired (4,088) (57,253) 0
Investments in unconsolidated entities 0 (421) (3,261)
Return of capital from unconsolidated entities 68 176 1,621
Advances to/from subsidiaries 0 0 0
Net cash used in investing activities (25,125) (74,148) (13,783)
Cash flows from financing activities:      
Repayment of debt (576,548) (522,465) (274,436)
Proceeds from issuance of new debt 500,000 400,000 250,000
Repayment of borrowings from credit facility (425,000) (225,000) (25,000)
Borrowings from credit facility 425,000 225,000 25,000
Debt issuance costs (6,137) (6,272) (4,919)
Other financing activities (1,655) (3,314) (391)
Repurchase of common stock (34,624) 0 0
Advances to/from subsidiaries 0 0 0
Net cash used in financing activities (118,964) (132,051) (29,746)
Decrease in cash and cash equivalents (30,454) (151,361) 61,333
Cash, cash equivalents, and restricted cash at end of period 122,794 153,248 304,609
Cash, cash equivalents, and restricted cash at beginning of period 153,248 304,609 243,276
Consolidating Adjustments      
Condensed Financial Statements, Captions [Line Items]      
Net cash (used in) provided by operating activities 0 0 0
Cash flows from investing activities:      
Capital expenditures 0 0 0
Proceeds from sale of fixed assets 0 0 0
Acquisition, net of cash acquired 0  
Investments in unconsolidated entities   0 0
Return of capital from unconsolidated entities 0 0 0
Advances to/from subsidiaries (204,001) 56,179 (148,120)
Net cash used in investing activities (204,001) 56,179 (148,120)
Cash flows from financing activities:      
Repayment of debt 0 0 0
Proceeds from issuance of new debt 0 0 0
Repayment of borrowings from credit facility 0 0 0
Borrowings from credit facility 0 0 0
Debt issuance costs 0 0 0
Other financing activities 0 0 0
Repurchase of common stock 0    
Advances to/from subsidiaries 204,001 (49,018) 145,459
Net cash used in financing activities 204,001 (49,018) 145,459
Decrease in cash and cash equivalents 0 7,161 (2,661)
Cash, cash equivalents, and restricted cash at end of period 0 0 (7,161)
Cash, cash equivalents, and restricted cash at beginning of period 0 (7,161) (4,500)
Beazer Homes USA, Inc.      
Condensed Financial Statements, Captions [Line Items]      
Net cash (used in) provided by operating activities (107,882) (1,163) (65,093)
Cash flows from investing activities:      
Capital expenditures 0 0 0
Proceeds from sale of fixed assets 0 0 0
Acquisition, net of cash acquired 0 0  
Investments in unconsolidated entities   0 0
Return of capital from unconsolidated entities 0 0 0
Advances to/from subsidiaries 204,555 (56,182) 148,081
Net cash used in investing activities 204,555 (56,182) 148,081
Cash flows from financing activities:      
Repayment of debt (573,589) (522,465) (261,999)
Proceeds from issuance of new debt 500,000 400,000 250,000
Repayment of borrowings from credit facility (425,000) (225,000) (25,000)
Borrowings from credit facility 425,000 225,000 25,000
Debt issuance costs (6,137) (6,272) (4,919)
Other financing activities (1,655) (3,314) (391)
Repurchase of common stock (34,624)    
Advances to/from subsidiaries 0 0 0
Net cash used in financing activities (116,005) (132,051) (17,309)
Decrease in cash and cash equivalents (19,332) (189,396) 65,679
Cash, cash equivalents, and restricted cash at end of period 85,464 104,796 294,192
Cash, cash equivalents, and restricted cash at beginning of period 104,796 294,192 228,513
Guarantor Subsidiaries      
Condensed Financial Statements, Captions [Line Items]      
Net cash (used in) provided by operating activities 221,529 56,153 170,129
Cash flows from investing activities:      
Capital expenditures (21,356) (17,020) (12,440)
Proceeds from sale of fixed assets 251 370 297
Acquisition, net of cash acquired (4,088) (57,253)  
Investments in unconsolidated entities   (421) (3,261)
Return of capital from unconsolidated entities 68 176 1,621
Advances to/from subsidiaries 0 0 0
Net cash used in investing activities (25,125) (74,148) (13,783)
Cash flows from financing activities:      
Repayment of debt (2,959) 0 (12,437)
Proceeds from issuance of new debt 0 0 0
Repayment of borrowings from credit facility 0 0 0
Borrowings from credit facility 0 0 0
Debt issuance costs 0 0 0
Other financing activities 0 0 0
Repurchase of common stock 0    
Advances to/from subsidiaries (204,001) 49,018 (145,459)
Net cash used in financing activities (206,960) 49,018 (157,896)
Decrease in cash and cash equivalents (10,556) 31,023 (1,550)
Cash, cash equivalents, and restricted cash at end of period 37,321 47,877 16,854
Cash, cash equivalents, and restricted cash at beginning of period 47,877 16,854 18,404
Non-Guarantor Subsidiaries      
Condensed Financial Statements, Captions [Line Items]      
Net cash (used in) provided by operating activities (12) (152) (174)
Cash flows from investing activities:      
Capital expenditures 0 0 0
Proceeds from sale of fixed assets 0 0 0
Acquisition, net of cash acquired 0  
Investments in unconsolidated entities   0 0
Return of capital from unconsolidated entities 0 0 0
Advances to/from subsidiaries (554) 3 39
Net cash used in investing activities (554) 3 39
Cash flows from financing activities:      
Repayment of debt 0 0 0
Proceeds from issuance of new debt 0 0 0
Repayment of borrowings from credit facility 0 0 0
Borrowings from credit facility 0 0 0
Debt issuance costs 0 0 0
Other financing activities 0 0 0
Repurchase of common stock 0    
Advances to/from subsidiaries 0   0
Net cash used in financing activities 0 0 0
Decrease in cash and cash equivalents (566) (149) (135)
Cash, cash equivalents, and restricted cash at end of period 9 575 724
Cash, cash equivalents, and restricted cash at beginning of period $ 575 $ 724 $ 859